PYGO1
Basic information
Region (hg38): 15:55538884-55588947
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PYGO1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 25 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 0 | 0 |
Variants in PYGO1
This is a list of pathogenic ClinVar variants found in the PYGO1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-55546051-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
15-55546288-T-A | not specified | Uncertain significance (Sep 30, 2024) | ||
15-55546318-C-G | not specified | Uncertain significance (Jun 25, 2024) | ||
15-55546376-T-A | not specified | Uncertain significance (Nov 14, 2023) | ||
15-55546444-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
15-55546552-C-T | not specified | Uncertain significance (Sep 11, 2024) | ||
15-55546574-G-T | not specified | Uncertain significance (Aug 16, 2021) | ||
15-55546636-A-G | not specified | Uncertain significance (Jun 24, 2022) | ||
15-55546681-G-C | not specified | Uncertain significance (Jun 25, 2024) | ||
15-55546688-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
15-55546690-G-T | not specified | Uncertain significance (Jan 09, 2024) | ||
15-55546723-A-C | not specified | Uncertain significance (Jul 25, 2023) | ||
15-55546742-C-A | not specified | Uncertain significance (Apr 22, 2022) | ||
15-55546754-T-C | not specified | Uncertain significance (Sep 14, 2023) | ||
15-55546778-C-G | not specified | Uncertain significance (Jul 14, 2021) | ||
15-55546895-G-C | not specified | Uncertain significance (Jun 01, 2023) | ||
15-55546925-C-G | not specified | Uncertain significance (Aug 01, 2024) | ||
15-55546934-G-C | not specified | Uncertain significance (Dec 12, 2023) | ||
15-55546955-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
15-55546981-T-C | not specified | Uncertain significance (Jul 29, 2023) | ||
15-55547089-T-C | not specified | Uncertain significance (Sep 22, 2023) | ||
15-55547107-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
15-55547110-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
15-55547140-G-C | not specified | Uncertain significance (Jun 28, 2022) | ||
15-55548927-G-A | not specified | Uncertain significance (Sep 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PYGO1 | protein_coding | protein_coding | ENST00000302000 | 3 | 50058 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.987 | 0.0132 | 125722 | 0 | 2 | 125724 | 0.00000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.109 | 232 | 227 | 1.02 | 0.0000118 | 2773 |
Missense in Polyphen | 73 | 77.159 | 0.9461 | 906 | ||
Synonymous | -0.542 | 90 | 83.7 | 1.08 | 0.00000462 | 829 |
Loss of Function | 3.35 | 0 | 13.1 | 0.00 | 8.02e-7 | 151 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000880 | 0.00000879 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in signal transduction through the Wnt pathway.;
- Pathway
- Wnt-beta-catenin Signaling Pathway in Leukemia;Signaling by WNT;Signal Transduction;Wnt Canonical;Formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Wnt Mammals
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.19
Haploinsufficiency Scores
- pHI
- 0.0892
- hipred
- Y
- hipred_score
- 0.853
- ghis
- 0.499
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.440
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pygo1
- Phenotype
- cellular phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; renal/urinary system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype;
Gene ontology
- Biological process
- kidney development;hematopoietic progenitor cell differentiation;spermatid nucleus differentiation;post-embryonic development;protein localization to nucleus;positive regulation of transcription by RNA polymerase II;canonical Wnt signaling pathway;beta-catenin-TCF complex assembly
- Cellular component
- nucleoplasm
- Molecular function
- protein binding;methylated histone binding;metal ion binding